Ketamine Infusions Effective as Super-Refractory Status Epilepticus Treatment
Ketamine infusion significantly decreased seizure burden within 24 hours in patients with super-refractory status epilepticus.
Status Epilepticus
Clinicians Call for Optimization of Status Epilepticus ICU Care During COVID-19 Era
During COVID-19, clinicians will be challenged by a lack of ICU resources and ventilators to manage patients with status epilepticus.
Risk for Cardiovascular Disease Found to Be Higher in Status Epilepticus
Individuals with vs without status epilepticus were found to have a greater prevalence of cardiovascular risk factors and a higher risk of developing cardiovascular diseases.
Second-Line Treatment of Pediatric Status Epilepticus: Levetiracetam vs Phenytoin
Results suggest that levetiracetam could be considered as an alternative treatment to phenytoin for second-line management of pediatric convulsive status epilepticus.
More Accurate Prediction of Premorbid Recovery in Status Epilepticus With STESS, GCS
Investigators examined various scoring systems to predict recovery to premorbid neurological and functional status in critically ill patients with status epilepticus.
Salzburg Consensus Criteria May Improve EEG Diagnostic Accuracy in Nonconvulsive Status Epilepticus
Researchers sought to determine whether the Salzburg Consensus Criteria yielded similar diagnostic results by an inexperienced EEG reader compared with an experienced EEG reader not using the SCC.
Characteristics Linked to Favorable Status Epilepticus Outcome Identified
Researchers used readily available clinical parameters to determine risk for prolonged status epilepticus at seizure onset, and to predict which patients they anticipated might experience a full recovery.
Aggressive, Prolonged Treatment for Refractory Status Epilepticus May Be Justified With Good Neurologic Prognosis
Aggressive and prolonged treatment of refractory status epilepticus may be justified in patients with cardiac arrest with favorable multimodal prognostic indicators.
Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
There are considerations for treating these seizures as part of the overall goals of palliative care, which include the family’s experience.
New Formulation of Status Epilepticus Treatment To Be Reviewed
The NDA for IM/IV Captisol-Enabled Fosphenytoin has been accepted for review and given a Prescription Drug Fee User Act date, by the FDA.
-
Loading...
-
Loading...
Next post in Epilepsy
